via University of Aberdeen
A new drug being trialled for treating breast cancer and diabetes has been shown to ‘melt away’ the fat inside arteries that can cause heart attacks and strokes.
Researchers from the University of Aberdeen, using pre-clinical mouse models, showed that just a single dose of the drug (Trodusquemine) completely reversed the effects of a disease that causes a host of heart problems.
Atherosclerosis is the build-up of fatty material inside the arteries.
Over time this fatty material can grow bigger until your arteries become so narrow that not enough blood can pass through.
Atherosclerosis is the condition that causes most heart attacks and strokes.
In pre-clinical tests, mice with set-in atherosclerosis, mimicking what happens in humans, had less fatty plaques in their arteries whether they had regular doses over time or just a single dose of Trodusquemine.
The drug works by stopping an enzyme called PTP1B, which is normally increased in people with obesity or diabetes and conditions involving prolonged inflammation such as sepsis, inflamed diabetic foot ulcers and allergic lung inflammation. The researchers found that it also stimulated the action of another protein (AMPK), which effectively mimics exercise and reduces chronic inflammation.
It has already been shown to be effective with diabetes and breast cancer patients but this is the first time the drug has been shown to have benefits for long-term cardiovascular disease.
The £236,000 study was funded by the British Heart Foundation.
Professor Mirela Delibegovic and Dr Dawn Thompson from the University of Aberdeen’s Institute of Medical Sciences who led the study said: “All humans have some level of atherosclerosis. As you age you start to develop these fatty streaks inside your arteries. It is a big problem for people who are overweight or have underlying cardiovascular conditions.”
“Trodusquemine has already been trialled for treatment of diabetes and breast cancer but this is the first time it has been used in models of atherosclerosis.
“These have only been tested at pre-clinical level, in mice, so far but the results were quite impressive and showed that just a single dose of this drug seemed to completely reverse the effects of arthrosclerosis.
“The next step is to test the ability of this drug to improve outcomes in human patients with developed atherosclerosis and cardiovascular disease”.
Learn more: Drug ‘melts away’ fat inside arteries
The Latest on: Atherosclerosis
[google_news title=”” keyword=”atherosclerosis ” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Watch out! High salt diet may harden your arterieson March 31, 2023 at 4:33 am
Atherosclerosis is a narrowing of the arteries with deposits called plaque. Blood flow is impaired in arteries supplying the heart and brain with blood, raising the risks of heart attack and stroke.
- Black sea urchin extract shows promise in combating atherosclerosison March 30, 2023 at 7:28 pm
A team of Italian scientists has identified potential anti-inflammatory and vasculoprotective effects of red cell extracts of the Black Sea urchin Arbacia lixula. The study has been published in the ...
- Vascular Proliferation and Atherosclerosis: New Perspectives and Therapeutic Strategieson March 30, 2023 at 5:00 pm
In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...
- Triglyceride-Glucose Index May Be a Marker for Atherosclerosis in Psoriatic Arthritison March 30, 2023 at 6:24 am
Researchers studied the role of triglyceride-glucose index in atherosclerotic risk among patients with psoriatic arthritis.
- Subclinical coronary atherosclerosis tied to more than 8-fold increase in MI riskon March 29, 2023 at 11:00 pm
Denmark: In middle-aged, asymptomatic adults, subclinical, obstructive coronary atherosclerosis is linked with a more than 8-fold increased risk for myocardial infarction over three years than those ...
- Heart disease: Nearly half of adults over 40 may have 'hidden' conditionon March 28, 2023 at 2:07 pm
A study found people without known cardiovascular disease but have undetected obstructive coronary atherosclerosis increase their risk for a heart attack eightfold.
- MI Risk Increased With Subclinical, Obstructive Coronary Atherosclerosison March 28, 2023 at 8:48 am
Subclinical, obstructive coronary atherosclerosis is associated with increased risk for myocardial infarction in asymptomatic persons aged 40 years and older, according to a ...
- Asymptomatic, CT angiography-detected coronary artery disease associated with 8-fold increased risk for heart attackon March 27, 2023 at 2:26 pm
A cohort study of more than 9,000 persons found that in asymptomatic middle-aged persons without known cardiovascular disease, subclinical, obstructive coronary atherosclerosis is associated with a ...
- Nearly Half of Adults Over 40 May Have 'Hidden' Heart Disease: What to Knowon March 27, 2023 at 8:33 am
New research published today suggests that heart disease may develop at an early age and remain latent for many years. Researchers found nearly half of adults in the study had signs of coronary heart ...
- Watching atherosclerosis as it developson March 16, 2023 at 7:45 am
Researchers at the University of Tübingen have developed a new method to better study atherosclerosis in mice. The non-invasive imaging method helps to better understand and treat narrowing of blood ...
via Google News and Bing News
